Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa
Author:
Affiliation:
1. NUCEL - School of Medicine, University of Sao Paulo, São Paulo, SP, Brazil
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543776.2019.1608181
Reference81 articles.
1. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB
2. Dilemmas in distinguishing between dominant and recessive forms of dystrophic epidermolysis bullosa
3. Human type VII collagen: cDNA cloning and chromosomal mapping of the gene.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dystrophic epidermolysis bullosa: from disease biology to biologic therapy;British Journal of Dermatology;2024-04-29
2. Nonintensive topical gentamicin treatment of patients with severe epidermolysis bullosa caused by nonsense mutations;JEADV Clinical Practice;2023-12-20
3. Genome Editing in Therapy of Genodermatoses;Molecular Biology;2022-12
4. The potential of gene therapy for recessive dystrophic epidermolysis bullosa;British Journal of Dermatology;2021-12-03
5. Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa;JCI Insight;2021-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3